Hey, guys. How are y'all doing today? Welcome, the worldwide broadcast of the Ted and Austin

Brower Show, bringing you the latest world news and health research. I hope you guys are having

a fantastic day today. Got a lot of good health articles, a lot of positive stuff. We're going to go over today on today's show. I hope you guys are having a fantastic day today. Got a lot of good health articles, a lot of positive stuff.

We're going to go over today on today's show.

I hope you guys are ready for a good time.

Be sure to check out different product sales that we got going on.

I'm going to leave the D310,000 K2 up on sale for a little bit more today.

You guys know the product of the week changes every Wednesday. And the new winner is going to be the ultimate multiple powder, which I know that's one of y'all's favorite.

I actually is going to make some up here in a little bit.

I had some more with the other shake.

But, yeah, so I'll leave the D3 up.

There's had a lot of people that are wanting to stock up on that in the last day on sale.

So I will put that up there shortly this afternoon. And also, this is an article that came out here that I wanted

to cover, giving everybody kind of a heads up on this, because I know people are starting

to realize how not a fun, safe fad that it is. OZMPA gets hit with another study showing that it

causes a significant risk of age-related eye-conditioned problems now.

Whoa.

This is research recently published in JAMA, found that patients taking the peptide-1 receptor

antagonists like Ozzympic, Wagovi, so forth, had more than twice, more than twice

the risk of developing neovascular age-related macular degeneration,

also known as wet AMD, leading cause of blindness and older adults.

Now, the research analyzed health records from Ontario, Canada, involving more than

...